1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Transnational Cannabis Ltd.

Transnational Cannabis Ltd.

TRCNF
Transnational Cannabis Ltd.US flagOther OTC
0.00
USD
- -
- -
29,564.00Market Cap
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-0.01
-0.04
-0.01
-0.03
-0.04
-0.26
-0.02
-0.04
-0.02
-0.07
-0.06
-0.37
-0.23
Free Cash Flow per Basic Share
-0.01
-0.01
-0.01
-0.02
-0.04
-0.08
-0.01
-0.04
- -
-0.04
-0.03
-0.05
-0.06
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
-0.11
-0.09
-0.09
-0.02
-0.42
-0.08
-0.03
-0.04
-0.09
-0.09
0.29
0.14
Tangible Book Value per Share
- -
0.01
0.03
0.01
0.01
-0.02
-0.01
0.01
- -
-0.02
-0.01
0.02
-0.03
Basic Weighted Avg Shares
9
9
13
20
9
1
6
14
16
11
17
164
600
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
-560.08
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
Net Income, GAAP
- -
- -
- -
-1
- -
- -
- -
-1
- -
-1
-1
-60
-140
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
-579.72
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
2
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
4
32
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
63
47
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-151.82

Capital Structure

FRC

•

in mil. unless spec.
May'20
Aug'20
Nov'20
ST Debt
- -
- -
- -
LT Borrowings
28
28
32
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
675
706
706
Market Capitalization
57
30
24

Working Capital

FRC

•

in mil. unless spec.
May'20
Aug'20
Nov'20
Total Current Assets
13
7
3
Cash, Cash Equivalents & STI
5
2
1
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
3
1
Payables & Accruals
1
3
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-6,051.52%
-12,102.48%
-65,301.02%
Free Cash Flow
360.64%
667.06%
1,669.64%
Net Income, GAAP
659.82%
1,304.87%
5,998.6%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2018
- -
- -
- -
- -
- -
2019
- -
- -
- -
- -
- -
2020
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2018
- -
- -
-0.01
- -
-0.06
2019
- -
-0.04
-0.05
- -
-0.37
2020
-0.13
-0.02
-0.04
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2018
- -
- -
- -
- -
- -
2019
- -
- -
- -
- -
- -
2020
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
David Shpilt
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
789 West Pender Street Vancouver BC Canada V6C 1H2
IPO Date
Aug 28, 2018
Website
intlcannabiscorp.com
Similar Companies
Mojave Brands Inc. (HHPHF)
Refined Metals Corp. (RMC.CN)
DongKook Pharmaceutical Co., Ltd. (086450.KQ)
Daito Pharmaceutical Co.,Ltd. (4577.T)
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329.SS)
Greenrise Global Brands Inc. (XCX.CN)
Business
Transnational Cannabis Ltd (TRCNF) engages in the cannabis business through its subsidiaries, focusing on cultivation, production, processing, distribution, and sale of cannabis and derivative products for medicinal, recreational, and industrial uses; it holds licenses to cultivate, manufacture, supply, hold, import, export, and transport cannabis internationally, with operations spanning Canada, Colombia, the Kingdom of Lesotho, Denmark, Greece, and other regions. The company offers core products including medical marijuana, cannabinoid extracts, pharmaceutical-grade cannabis formulations, industrial hemp, and related biomedical derivatives through projects such as BioCanna ADM and Kaneh Bosm EPC, targeting healthcare, wellness, pharmaceuticals, and consumer goods sectors with high-quality, compliant offerings. Founded in 2006 and headquartered in Toronto, Canada, with additional presence noted in Vancouver, Transnational Cannabis Ltd, formerly known as ICC International Cannabis Corp, maintains a global footprint emphasizing regulatory compliance and supply chain efficiency across emerging cannabis markets. Recent developments include its evolution from prior names like ICC Labs Inc, with no major publicly reported acquisitions, partnerships, funding rounds, or operational shifts in the last 1-2 years, positioning it amid evolving international regulations without significant strategic changes noted in available data.